Cardiome Pharma shares soared 40 percent on over 3 million shares traded Tuesday.
The company has reached a deal with Merck & Co. to settle debt obligations related to vernakalant, an atrial fibrillation treatment.
Going forward ... (see research report)
Copyright ® 2016. The Bedford Report. All Rights Reserved.